[1]李 鑫,刘凤永,袁宏军,等.纳米刀治疗肝癌 [J].介入放射学杂志,2017,(10):939-943.
 LI Xin,LIU Fengyong,YUAN Hongjun,et al.Nano knife: a newly- developed technique for the treatment of liver cancers[J].journal interventional radiology,2017,(10):939-943.
点击复制

纳米刀治疗肝癌 



()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2017年10期
页码:
939-943
栏目:
综述
出版日期:
2017-10-25

文章信息/Info

Title:
Nano knife: a newly- developed technique for the treatment of liver cancers
作者:
李 鑫 刘凤永 袁宏军 陈现现 左太阳 管 阳 付金鑫 王茂强
Author(s):
LI Xin LIU Fengyong YUAN Hongjun CHEN Xianxian ZUO Taiyang GUAN Yang FU Jinxin WANG Maoqiang
Department of Interventional Radiology, General Hospital of PLA, Beijing 100853, China
关键词:
【关键词】 不可逆电穿孔 纳米刀 肝癌 治疗
文献标志码:
A
摘要:
【摘要】 肝癌是高发病率和高致死率的恶性肿瘤。随着分子生物学以及科学技术的发展,基于不可逆电穿孔原理衍变而来的纳米刀技术在治疗肝癌上已经进入人们的视野。在这里,我们主要从纳米刀治疗肝癌的原理、优势以及最新的实验和临床进展等方面对纳米刀治疗肝癌作一综述。

参考文献/References:

[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65: 87- 108.
[2] Lai EC, Fan ST, Lo CM, et al. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients[J]. Ann Surg, 1995, 221: 291- 298.
[3] Cho YK, Kim JK, Kim MY, et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies[J]. Hepatology, 2009, 49: 453- 459.
[4] Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors[J]. J Vasc Interv Radiol, 2003, 14: 1267- 1274.
[5] Yu NC, Raman SS, Kim YJ, et al. Microwave liver ablation: influence of hepatic vein size on heat- sink effect in a porcine model[J]. J Vasc Interv Radiol, 2008, 19: 1087- 1092.
[6] Lu DS, Kee ST, Lee EW. Irreversible electroporation: ready for prime time?[J]. Tech Vasc Interv Radiol, 2013, 16: 277- 286.
[7] Rubinsky B. Irreversible electroporation in medicine[J]. Technol Cancer Res Treat, 2007, 6: 255- 260.
[8] Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research[J]. Acta Physiol Scand, 2003, 177: 437- 447.
[9] 姚陈果, 孙才新, 米 彦, 等. 陡脉冲对恶性肿瘤细胞不可逆性电击穿的实验研究[J]. 中国生物医学工程学报, 2004, 23: 92- 97.
[10] Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation[J]. Ann Biomed Eng, 2005, 33: 223- 231.
[11] Song Y, Zheng J, Yan M, et al. The effect of irreversible electroporation on the femur: experimental study in a rabbit model[J]. Sci Rep, 2015, 5: 18187.
[12] Schoellnast H, Monette S, Ezell PC, et al. Irreversible electroporation adjacent to the rectum: evaluation of pathological effects in a pig model[J]. Cardiovasc Intervent Radiol, 2013, 36: 213- 220.
[13] Narayanan G, Hosein PJ, Arora G, et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma[J]. J Vasc Interv Radiol, 2012, 23: 1613- 1621.
[14] Pech M, Janitzky A, Wendler JJ, et al. Irreversible electroporation of renal cell carcinoma: a first- in- man phase Ⅰ clinical study[J]. Cardiovasc Intervent Radiol, 2011, 34: 132- 138.
[15] Ben- David E, Appelbaum L, Sosna J, et al. Characterization of irreversible electroporation ablation in in vivo porcine liver[J]. AJR Am J Roentgenol, 2012, 198: W62- W68.
[16] Delicque J, Boulin M, Guiu B, et al. Interventional oncology for hepatocellular carcinoma[J]. Clin Res Hepatol Gastroenterol, 2016, 40: 530- 537.
[17] Lee EW, Loh CT, Kee ST. Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation[J]. Technol Cancer Res Treat, 2007, 6: 287- 294.
[18] Guo Y, Zhang Y, Klein R, et al. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma[J]. Cancer Res, 2010, 70: 1555- 1563.
[19] Lee EW, Wong D, Tafti BA, et al. Irreversible electroporation in eradication of rabbit VX2 liver tumor[J]. J Vasc Interv Radiol, 2012, 23: 833- 840.
[20] Wandel A, Ben- David E, Ulusoy BS, et al. Optimizing irreversible electroporation ablation with a bipolar electrode[J]. J Vasc Interv Radiol, 2016, 27: 1441- 1450.
[21] 朱统寅, 孙军辉, 陈新华, 等. CT导引纳米刀消融猪肝脏可行性实验研究[J]. 介入放射学杂志, 2016, 25: 337- 340.
[22] 梁 冰, 牛立志, 曾健滢, 等. 不可逆电穿孔消融兔胆囊侧肝脏病理学观察[J]. 介入放射学杂志, 2014, 23: 320- 324.
[23] 王茂强, 段 峰, 阎洁羽, 等. 即时性TACE联合射频消融治疗巨大肝癌[J]. 中华医学杂志, 2015, 95: 2170- 2173.
[24] 姚红响, 陈根生, 诸葛英, 等. 肝动脉化疗栓塞联合CT引导射频消融序贯治疗中小肝癌的临床应用[J]. 介入放射学杂志, 2012, 21: 301- 304.
[25] Tam AL, Melancon MP, Abdelsalam M, et al. Imaging intratumoral nanoparticle uptake after combining nanoembo- lization with various ablative therapies in hepatic VX2 rabbit tumors[J]. J Biomed Nanotechnol, 2016, 12: 296- 307.
[26] Vollherbst D, Bertheau RC, Fritz S, et al. Electrochemical effects after transarterial chemoembolization in combination with percutaneous irreversible electroporation: observations in an acute porcine liver model[J]. J Vasc Interv Radiol, 2016, 27: 913.e2- 921.e2.
[27] Bhonsle S, Bonakdar M, Neal RE 2nd, et al. Characterization of irreversible electroporation ablation with a validated perfused organ model[J]. J Vasc Interv Radiol, 2016, 27: 1913.e2.- 1922.e2.
[28] Cheng RG, Bhattacharya R, Yeh MM, et al. Irreversible electroporation can effectively ablate hepatocellular carcinoma to complete pathologic necrosis[J]. J Vasc Interv Radiol, 2015, 26: 1184- 1188.
[29] Herwald SE, Chen JH, Arellano RS. Irreversible electroporation for treatment of hepatocellular carcinoma adjacent to the gallbladder[J]. J Vasc Interv Radiol, 2016, 27: 1093- 1094.
[30] Zeng J, Liu G, Li ZH, et al. The safety and efficacy of irreversible electroporation for large hepatocellular carcinoma[J]. Technol Cancer Res Treat, 2017, 16: 120- 124.
[31] Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio- frequency ablation of medium and large lesions[J]. Radiology, 2000, 214: 761- 768.
[32] Hosein PJ, Echenique A, Loaiza- Bonilla A, et al. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system[J]. J Vasc Interv Radiol, 2014, 25: 1233.e2- 1239.e2.
[33] Niessen C, Beyer LP, Pregler B, et al. Percutaneous ablation of hepatic tumors using irreversible electroporation: a prospective safety and midterm efficacy study in 34 patients[J]. J Vasc Interv Radiol, 2016, 27: 480- 486.
[34] Fruhling P, Nilsson A, Duraj F, et al. Single- center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation(IRE) ablation of liver tumors in humans: short to mid- term results[J]. Eur J Surg Oncol, 2017, 43: 751- 757.
[35] Lencioni R, Crocetti L, Narayanan G. Irreversible electroporation in the treatment of hepatocellular carcinoma[J]. Tech Vasc Interv Radiol, 2015, 18: 135- 139.
[36] 孙 钢. 不可逆电穿孔技术消融肿瘤研究进展[J]. 介入放射学杂志, 2015, 24: 277- 281.
[37] Faroja M, Ahmed M, Appelbaum L,等. 不可逆电穿孔消融术:全是非热性损伤吗?[J]. 国际医学放射学杂志, 2013, 36: 170- 171.
[38] Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operating theater” anesthesia[J]. Anesth Analg, 2010, 110: 1305- 1309.
[39] Thomson KR, Cheung W, Ellis SJ, et al. Investigation of the safety of irreversible electroporation in humans[J]. J Vasc Interv Radiol, 2011, 22: 611- 621.
[40] Martin RC, Schwartz E, Adams J, et al. Intraoperative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors[J]. Anesth Pain Med, 2015, 5: e22786.

相似文献/References:

[1]孙 钢.不可逆电穿孔技术消融肿瘤研究进展 [J].介入放射学杂志,2015,(04):277.
 SUN Gang..Irreversible electroporation technology for ablation treatment of tumors: recent progress in research [J].journal interventional radiology,2015,(10):277.
[2]牛立志,曾健滢,罗小美,等.胃癌术后复发性病变的不可逆电穿孔消融1例[J].介入放射学杂志,2016,(01):50.
 NIU Li- zhi,ZENG Jian- ying,LUO Xiao- mei,et al.Irreversible electroporation ablation for postoperative recurrent lesions of gastric cancer: report of one case[J].journal interventional radiology,2016,(10):50.
[3]朱统寅,孙军辉,陈新华,等.CT导引纳米刀消融猪肝脏可行性实验研究[J].介入放射学杂志,2016,(04):337.
 ZHU Tong- yin,SUN Jun- hui,CHEN Xin- hua,et al.CT- guided NanoKnife ablation of experimental pig liver: a feasibility study[J].journal interventional radiology,2016,(10):337.
[4]牛立志,曾健滢,张怡湜,等.不可逆电穿孔消融治疗胰腺癌的安全性及近期疗效观察[J].介入放射学杂志,2016,(03):225.
 NIU Li- zhi,ZENG Jian- ying,ZHANG Yi- shi,et al.Irreversible electroporation ablation therapy for pancreatic adenocarcinoma: observation of its safety and short- term effect[J].journal interventional radiology,2016,(10):225.
[5]刘 钦,丁晓毅,王忠敏,等.CT引导下不可逆电穿孔治疗肝门部胆管细胞癌1例[J].介入放射学杂志,2016,(08):717.
 LIU Qin,DING Xiao-yi,WANG Zhong-min,et al.CT-guided irreversible electroporation for the treatment of hepatic hilar cholangiocarcinoma: report of one case [J].journal interventional radiology,2016,(10):717.
[6]秦子淋,曾健滢,牛立志.不可逆电穿孔消融治疗肝恶性肿瘤现状[J].介入放射学杂志,2017,(03):285.
 QIN Zilin,ZENG Jianying,NIU Lizhi.Irreversible electroporation ablation for the treatment of malignant tumors of liver: present clinical situation[J].journal interventional radiology,2017,(10):285.
[7]刘树鹏,徐炯源,冷 尹,等.不可逆电穿孔消融联合化疗治疗肝胆管细胞癌1例[J].介入放射学杂志,2019,28(06):530.
 LIU Shupeng,XU Jiongyuan,LENG Yin,et al.Irreversible electroporation ablation combined with chemotherapy for the treatment of intrahepatic cholangiocarcinoma: report of one case[J].journal interventional radiology,2019,28(10):530.

备注/Memo

备注/Memo:
(收稿日期:2017-03-12)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2017-10-15